While the three-dimensional model of positive, negative, and disorganization symptoms is the most popular, it has been criticized as too simplistic and more complex models have been proposed; however, there is no consensus as to the number and nature of dimensions necessary to encompass the entirety of heterogenous symptoms of schizophrenia.5

Factor analytical studies have identified additional domains including mood symptoms, motor symptoms, impaired insight (anosognosia), and cognitive impairment.1,6 Cognitive impairments are highly prevalent in schizophrenia, including deficits in episodic memory, processing speed, verbal fluency, and attention and are strongly linked to poor social and vocational outcome.1 Cognitive impairment is not a diagnostic feature of schizophrenia.7

Symptom domains vary across illness course. Positive symptoms typically characterize the first episode of psychosis, and often follow an episodic course, with periods of relapse and remission, although some individuals have residual persisting long-term psychotic symptoms.1,2 Subtle disorganization and cognitive abnormalities may be detectable during the premorbid phase.1,2 Negative symptoms frequently emerge in the prodromal phase before first episode of psychosis and tend to be persistent, contributing substantially to long term disability and poor functional outcomes.2,3,8

References:

1.Tandon R, Nasrallah HA, Keshavan KS. Schizophrenia, “just the facts” 4: clinical features and conceptualization. Schizophr Res 2009; 110: 1–23.

2.Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet 2022; 399: 473–486.

3.Correll CU, Schooler NR, Kane JM et al. Negative symptoms in schizophrenia: A review and clinical guide for recognition, assessment, and treatment. Neuropsychiatr Dis Treat 2020; 16: 519–534.

4.Blasio P, Giordano GM, Pezzella P et al. Negative symptoms in schizophrenia: definition, classification, and course. In: Vita A, Carpiniello B & Galderisi S, eds. Negative and cognitive symptoms in schizophrenia. Comprehensive Approach to Psychiatry 2025. vol 3.  Springer, Cham. https://doi.org/10.1007/978-3-032-06209-3_1.

5.Peralta V & Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 2001; 49: 269–85.

6.Wijers AA. The enigmatic phenotype: relevant signs and symptoms in schizophrenia. Eur J Psychiatry 2005; 19: 215–230.

7.Galderisi S & Marder SR. Cognitive impairment associated with schizophrenia: new research agenda. Schizophr Bull Open 2024; 5: sgae023.

8.Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia. Am J Psychiatry 2005; 162: 495–506.